Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

Grit S. Herter-Sprie, Houari Korideck, Camilla L. Christensen, Jan M. Herter, Kevin Rhee, Ross I. Berbeco, David G. Bennett, Esra A. Akbay, David Kozono, Raymond H. Mak, G. Mike Makrigiorgos, Alec C. Kimmelman, Kwok Kin Wong

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Close resemblance of murine and human trials is essential to achieve the best predictive value of animal-based translational cancer research. Kras-driven genetically engineered mouse models of non-small-cell lung cancer faithfully predict the response of human lung cancers to systemic chemotherapy. Owing to development of multifocal disease, however, these models have not been usable in studies of outcomes following focal radiotherapy (RT). We report the development of a preclinical platform to deliver state-of-The-Art image-guided RT in these models. Presence of a single tumour as usually diagnosed in patients is modelled by confined injection of adenoviral Cre recombinase. Furthermore, three-dimensional conformal planning and state-of-The-Art image-guided dose delivery are performed as in humans. We evaluate treatment efficacies of two different radiation regimens and find that Kras-driven tumours can temporarily be stabilized upon RT, whereas additional loss of either Lkb1 or p53 renders these lesions less responsive to RT.

Original languageEnglish (US)
Article number5870
JournalNature Communications
Volume5
DOIs
StatePublished - Jan 1 2014

Fingerprint

Image-Guided Radiotherapy
nodules
Radiotherapy
lungs
mice
radiation therapy
Lung Neoplasms
platforms
cancer
Tumors
Neoplasms
Translational Medical Research
tumors
Non-Small Cell Lung Carcinoma
Chemotherapy
chemotherapy
Outcome Assessment (Health Care)
lesions
Radiation
planning

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Herter-Sprie, G. S., Korideck, H., Christensen, C. L., Herter, J. M., Rhee, K., Berbeco, R. I., ... Wong, K. K. (2014). Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nature Communications, 5, [5870]. https://doi.org/10.1038/ncomms6870

Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. / Herter-Sprie, Grit S.; Korideck, Houari; Christensen, Camilla L.; Herter, Jan M.; Rhee, Kevin; Berbeco, Ross I.; Bennett, David G.; Akbay, Esra A.; Kozono, David; Mak, Raymond H.; Mike Makrigiorgos, G.; Kimmelman, Alec C.; Wong, Kwok Kin.

In: Nature Communications, Vol. 5, 5870, 01.01.2014.

Research output: Contribution to journalArticle

Herter-Sprie, GS, Korideck, H, Christensen, CL, Herter, JM, Rhee, K, Berbeco, RI, Bennett, DG, Akbay, EA, Kozono, D, Mak, RH, Mike Makrigiorgos, G, Kimmelman, AC & Wong, KK 2014, 'Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models', Nature Communications, vol. 5, 5870. https://doi.org/10.1038/ncomms6870
Herter-Sprie GS, Korideck H, Christensen CL, Herter JM, Rhee K, Berbeco RI et al. Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nature Communications. 2014 Jan 1;5. 5870. https://doi.org/10.1038/ncomms6870
Herter-Sprie, Grit S. ; Korideck, Houari ; Christensen, Camilla L. ; Herter, Jan M. ; Rhee, Kevin ; Berbeco, Ross I. ; Bennett, David G. ; Akbay, Esra A. ; Kozono, David ; Mak, Raymond H. ; Mike Makrigiorgos, G. ; Kimmelman, Alec C. ; Wong, Kwok Kin. / Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. In: Nature Communications. 2014 ; Vol. 5.
@article{62829ed19bf74fcfa7e948907fbbf5c0,
title = "Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models",
abstract = "Close resemblance of murine and human trials is essential to achieve the best predictive value of animal-based translational cancer research. Kras-driven genetically engineered mouse models of non-small-cell lung cancer faithfully predict the response of human lung cancers to systemic chemotherapy. Owing to development of multifocal disease, however, these models have not been usable in studies of outcomes following focal radiotherapy (RT). We report the development of a preclinical platform to deliver state-of-The-Art image-guided RT in these models. Presence of a single tumour as usually diagnosed in patients is modelled by confined injection of adenoviral Cre recombinase. Furthermore, three-dimensional conformal planning and state-of-The-Art image-guided dose delivery are performed as in humans. We evaluate treatment efficacies of two different radiation regimens and find that Kras-driven tumours can temporarily be stabilized upon RT, whereas additional loss of either Lkb1 or p53 renders these lesions less responsive to RT.",
author = "Herter-Sprie, {Grit S.} and Houari Korideck and Christensen, {Camilla L.} and Herter, {Jan M.} and Kevin Rhee and Berbeco, {Ross I.} and Bennett, {David G.} and Akbay, {Esra A.} and David Kozono and Mak, {Raymond H.} and {Mike Makrigiorgos}, G. and Kimmelman, {Alec C.} and Wong, {Kwok Kin}",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/ncomms6870",
language = "English (US)",
volume = "5",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models

AU - Herter-Sprie, Grit S.

AU - Korideck, Houari

AU - Christensen, Camilla L.

AU - Herter, Jan M.

AU - Rhee, Kevin

AU - Berbeco, Ross I.

AU - Bennett, David G.

AU - Akbay, Esra A.

AU - Kozono, David

AU - Mak, Raymond H.

AU - Mike Makrigiorgos, G.

AU - Kimmelman, Alec C.

AU - Wong, Kwok Kin

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Close resemblance of murine and human trials is essential to achieve the best predictive value of animal-based translational cancer research. Kras-driven genetically engineered mouse models of non-small-cell lung cancer faithfully predict the response of human lung cancers to systemic chemotherapy. Owing to development of multifocal disease, however, these models have not been usable in studies of outcomes following focal radiotherapy (RT). We report the development of a preclinical platform to deliver state-of-The-Art image-guided RT in these models. Presence of a single tumour as usually diagnosed in patients is modelled by confined injection of adenoviral Cre recombinase. Furthermore, three-dimensional conformal planning and state-of-The-Art image-guided dose delivery are performed as in humans. We evaluate treatment efficacies of two different radiation regimens and find that Kras-driven tumours can temporarily be stabilized upon RT, whereas additional loss of either Lkb1 or p53 renders these lesions less responsive to RT.

AB - Close resemblance of murine and human trials is essential to achieve the best predictive value of animal-based translational cancer research. Kras-driven genetically engineered mouse models of non-small-cell lung cancer faithfully predict the response of human lung cancers to systemic chemotherapy. Owing to development of multifocal disease, however, these models have not been usable in studies of outcomes following focal radiotherapy (RT). We report the development of a preclinical platform to deliver state-of-The-Art image-guided RT in these models. Presence of a single tumour as usually diagnosed in patients is modelled by confined injection of adenoviral Cre recombinase. Furthermore, three-dimensional conformal planning and state-of-The-Art image-guided dose delivery are performed as in humans. We evaluate treatment efficacies of two different radiation regimens and find that Kras-driven tumours can temporarily be stabilized upon RT, whereas additional loss of either Lkb1 or p53 renders these lesions less responsive to RT.

UR - http://www.scopus.com/inward/record.url?scp=84923385824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923385824&partnerID=8YFLogxK

U2 - 10.1038/ncomms6870

DO - 10.1038/ncomms6870

M3 - Article

VL - 5

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 5870

ER -